InsidersTradesSigma
Track the Pharmanutra CS - Pharmanutra - PHN - Cetilar AL Fianco di Fernando Alonso stock price and the full directors' dealings record of the company, a listed equity based in Italy. Shares are listed on the IT market, under the oversight of Consob. Operating in the Health Care sector, Pharmanutra CS - Pharmanutra - PHN - Cetilar AL Fianco di Fernando Alonso has published 1 reports. Market capitalisation: €799.5m. The latest transaction was disclosed on 26 May 2023 (Other). All data is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,597 of 29,062 companies
61.7
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.8x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 May 2023
Acerca de Pharmanutra CS - Pharmanutra - PHN - Cetilar AL Fianco di Fernando Alonso
Pharmanutra es una empresa especializada en el sector de la salud y farmacéutico, conocida por sus productos innovadores. Cotiza en el mercado XMIL y está asociada con la marca Cetilar, apoyada por el piloto de Fórmula 1 Fernando Alonso.